Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium flag Belgium · Delayed Price · Currency is EUR
6.12
+0.22 (3.73%)
Mar 31, 2025, 3:54 PM CET

Hyloris Pharmaceuticals Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Operating Revenue
8.462.090.93.10.18
Upgrade
Other Revenue
1.582.131.49--
Upgrade
Revenue
10.044.212.393.10.18
Upgrade
Revenue Growth (YoY)
138.30%76.54%-22.90%1669.14%92.31%
Upgrade
Cost of Revenue
0.230.090.090.110.15
Upgrade
Gross Profit
9.824.122.292.990.03
Upgrade
Selling, General & Admin
5.635.553.522.92.19
Upgrade
Research & Development
10.2714.4210.275.032.93
Upgrade
Other Operating Expenses
--0.015.38-0.02
Upgrade
Operating Expenses
15.8919.9713.813.315.11
Upgrade
Operating Income
-6.08-15.85-11.51-10.33-5.08
Upgrade
Interest Expense
-0.38-0.05-0.22-0.56-0.84
Upgrade
Interest & Investment Income
1.170.870.070.030.01
Upgrade
Earnings From Equity Investments
-0.08-0.15-0.13-0.19-
Upgrade
Currency Exchange Gain (Loss)
-0.020.35-0.190.28
Upgrade
Other Non Operating Income (Expenses)
0-0.22-0.23-0.03-1.57
Upgrade
EBT Excluding Unusual Items
-5.37-15.38-11.68-11.26-7.2
Upgrade
Gain (Loss) on Sale of Investments
-0.97----
Upgrade
Asset Writedown
----0.02-0.48
Upgrade
Other Unusual Items
---0.23-0.53
Upgrade
Pretax Income
-6.34-15.38-11.9-11.28-7.14
Upgrade
Income Tax Expense
--00.30
Upgrade
Earnings From Continuing Operations
-6.34-15.38-11.91-11.58-7.15
Upgrade
Net Income
-6.34-15.38-11.91-11.58-7.15
Upgrade
Net Income to Common
-6.34-15.38-11.91-11.58-7.15
Upgrade
Shares Outstanding (Basic)
-28272622
Upgrade
Shares Outstanding (Diluted)
-28272622
Upgrade
Shares Change (YoY)
-2.95%5.29%18.40%51.63%
Upgrade
EPS (Basic)
--0.55-0.44-0.45-0.33
Upgrade
EPS (Diluted)
--0.55-0.44-0.45-0.33
Upgrade
Free Cash Flow
-6.73-13.11-13.12-11.36-4.57
Upgrade
Free Cash Flow Per Share
--0.47-0.48-0.44-0.21
Upgrade
Gross Margin
97.74%97.79%96.06%96.54%17.14%
Upgrade
Operating Margin
-60.52%-376.03%-482.11%-333.50%-2900.57%
Upgrade
Profit Margin
-63.15%-364.97%-498.78%-374.00%-4082.86%
Upgrade
Free Cash Flow Margin
-67.04%-311.01%-549.69%-366.83%-2611.43%
Upgrade
EBITDA
-4.85-15.74-11.43-10.27-5.03
Upgrade
EBITDA Margin
-48.28%----
Upgrade
D&A For EBITDA
1.230.110.080.050.05
Upgrade
EBIT
-6.08-15.85-11.51-10.33-5.08
Upgrade
EBIT Margin
-60.52%----
Upgrade
Updated Oct 16, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.